Search in:

Advanced search

Neuropsychiatric Disease and Treatment Volume 9, 2013 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer’s disease

Osamu Kano1 Department of Neurology, Toho University Omori Medical Center, Tokyo, JapanCorrespondence[email protected]

Yoshihisa Urita2 Department of General Medicine and Emergency Care, Toho University Omori Medical Center, Tokyo, Japan

Hirono Ito1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

Takanori Takazawa1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

Yuji Kawase1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

Kiyoko Murata1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

Takehisa Hirayama1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

Ken Miura1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

Yuichi Ishikawa1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

Tetsuhito Kiyozuka3 Department of Neurology, Federation of National Public Service Personnel Mutual Aid Associations, Mishuku Hospital, Tokyo, Japan

Jo Aoyagi3 Department of Neurology, Federation of National Public Service Personnel Mutual Aid Associations, Mishuku Hospital, Tokyo, Japan

Yasuo Iwasaki1 Department of Neurology, Toho University Omori Medical Center, Tokyo, Japan

show all

Pages 1411-1415 | Published online: 18 Sep 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

JostBCGrossbergGTThe evolution of psychiatric symptoms in Alzheimer’s disease: a natural history studyJ Am Geriatr Soc1996449107810818790235
PubMed Web of Science ®Google Scholar
LopezOLBeckerJTSweetRAPsychiatric symptoms vary with the severity of dementia in probable Alzheimer’s diseaseJ Neuropsychiatry Clin Neurosci200315334635312928511
PubMed Web of Science ®Google Scholar
KanoOItoHTakazawaTClinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezilNeuropsychiatr Dis Treat2013925926523431041
PubMed Web of Science ®Google Scholar
WinbladBGrossbergGFrölichLIDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer diseaseNeurology2007694 Suppl 1S14S2217646619
PubMed Web of Science ®Google Scholar
NakamuraYImaiYShigetaMA 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer’s diseaseDement Geriatr Cogn Dis Extra20111116317922163242
PubMedGoogle Scholar
CevcGDrug delivery across the skinExpert Opin Investig Drugs199761218871937
PubMedGoogle Scholar
ScarzellaLCostanzaAVastolaKDomperidone is effective in the prevention of rivastigmine-related gastrointestinal disturbancesFunct Neurol200722210110417637213
PubMed Web of Science ®Google Scholar
KusanoMShimoyamaYSugimotoSDevelopment and evaluation of FSSG: frequency scale for the symptoms of GERDJ Gastroenterol200439988889115565409
PubMed Web of Science ®Google Scholar
LewisSJHeatonKWStool form scale as a useful guide to intestinal transit timeScand J Gastroenterol19973299209249299672
PubMed Web of Science ®Google Scholar
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology19843479399446610841
PubMed Web of Science ®Google Scholar
FolsteinMFFolsteinSEMcHughPR“Mini-mental state.” A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
PubMed Web of Science ®Google Scholar
ChampionMCHartnettMYenMDomperidone, a new dopamine antagonistCMAJ198613554574613527396
PubMed Web of Science ®Google Scholar
ReddymasuSCSoykanIMcCallumRWDomperidone: review of pharmacology and clinical applications in gastroenterologyAm J Gastroenterol200710292036204517488253
PubMed Web of Science ®Google Scholar
RogersSLDoodyRSMohsRCFriedhoffLTDonepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study GroupArch Intern Med19981589102110319588436
PubMed Web of Science ®Google Scholar
RaskindMAPeskindERWesselTYuanWGalantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study GroupNeurology200054122261226810881250
PubMed Web of Science ®Google Scholar
WinbladBMaintaining functional and behavioral abilities in Alzheimer diseaseAlzheimer Dis Assoc Disord200115Suppl 1S34S4011669508
PubMed Web of Science ®Google Scholar
TariotPNFarlowMRGrossbergGTMemantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trialJAMA2004291331732414734594
PubMed Web of Science ®Google Scholar
HowardRMcShaneRLindesayJDonepezil and memantine for moderate-to-severe Alzheimer’s diseaseN Engl J Med20123661089390322397651
PubMed Web of Science ®Google Scholar
CummingsJLSchneiderETariotPNGrahamSMBehavioral effects of memantine in Alzheimer disease patients receiving donepezil treatmentNeurology2006671576316832078
PubMed Web of Science ®Google Scholar
WilcockGHoweIColesHA long-term comparison of galantamine and donepezil in the treatment of Alzheimer’s diseaseDrugs Aging2003201077778912875613
PubMed Web of Science ®Google Scholar
CummingsJLThe neuropsychiatric inventory: assessing psychopathology in dementia patientsNeurology1997485 Suppl 6S10S169153155
PubMed Web of Science ®Google Scholar
MurmanDLChenQPowellMCKuoSBBradleyCJColendaCCThe incremental direct costs associated with behavioral symptoms in ADNeurology200259111721172912473759
PubMed Web of Science ®Google Scholar
LopezOLBeckerJTWahedASLong-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer diseaseJ Neurol Neurosurg Psychiatry200980660060719204022
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer’s disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer’s disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date